▼ SELL
10b5-1 Plan
$ Value
$1.4M
Shares
30,921
Price
$46
Filed
Dec 3
Insider
Name
Mackin James P
Title
President & CEO
CIK
0001408470
Roles
Officer
Transaction Details
Transaction Date
2025-12-02
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
800,993
Footnotes
The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 2, 2025. | Reflects weighted average price. Range of prices were between $45.25 to $46.09. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. | Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 5, 2020.
Filing Info
Mackin James P's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-03 | AORT | ▼ | $676K |
| 2026-03-02 | AORT | ▼ | $567K |
| 2026-03-02 | AORT | A | $0 |
| 2026-02-24 | AORT | ▼ | $497K |
| 2026-02-24 | AORT | A | $0 |
| 2026-02-23 | AORT | ▼ | $788K |
| 2025-12-03 | AORT | M | $916K |
| 2025-12-03 | AORT | ▼ | $1.4M |
| 2025-12-03 | AORT | M | $0 |
| 2025-12-02 | AORT | M | $916K |
Other Insiders at AORT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Horton Amy
VP, Chief Accounting Officer
|
— | $153K | 2026-03-03 |
|
Mackin James P
President & CEO
|
— | $2.5M | 2026-03-03 |
|
Berry Lance A
EVP, COO, CFO & Treasurer
|
— | $783K | 2026-03-03 |
|
Holloway Jean F
SVP, General Counsel
|
— | $744K | 2026-03-04 |
|
Davis John E
Chief Commercial Officer
|
— | $494K | 2026-03-03 |
|
Stanton Marshall S.
SVP, Clinical & MD Affair
|
— | $275K | 2026-03-03 |